Search Results
Jul 31, 2026, 10:44 ET Intensifying Wildfires and Hurricanes Raise New Questions About How America Builds Homes
actionable and free design solutions for your next project."ABOUT THE CONCRETE MASONRY CHECKOFFThe Concrete Masonry Checkoff (CMC) is an industry-funded initiative to support education, research and promotion of manufactured concrete masonry products in the United States. For more
More news about: Concrete Masonry Checkoff
Jul 28, 2026, 16:05 ET Kennametal Announces Board Leadership Transition
and CEO of Commercial Metals Company ("CMC"), a global manufacturer, recycler and marketer of steel and other metals. He joined CMC in April 2010 as Executive Vice President and Chief Operating Officer and other roles of increasing responsibility. Before joining CMC, Alvarado was the President of U.S.
More news about: Kennametal Inc.
Jul 28, 2026, 08:00 ET Torrey Pines Medicine Secures Angel Round to Advance Next-Generation Ultra-Long-Acting Peptide Therapeutics
entire drug discovery and development lifecycle, including target discovery, AI-assisted drug design, drug screening (pharmacology, pharmacokinetics, CMC development), preclinical evaluation, IND regulatory filings, and clinical trial execution, enabling seamless execution from bench to bedside.About
More news about: Torrey Pines Medicine
Jul 27, 2026, 09:12 ET DifGen Pharmaceuticals Receives FDA Clearance to Begin Clinical Development for a Single Injection treatment for Advanced Breast Cancer DFGN-101
study. A clinical endpoint/efficacy study is not required. The Agency's position was supported by the company's Chemistry, Manufacturing and Controls (CMC) data package and by results from a pilot pharmacokinetic study showing a PK profile comparable to that of the reference product.The clearance
More news about: DifGen Pharmaceuticals LLC
Jul 27, 2026, 09:00 ET AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem
AI-enabled workflow, AccPCC connects early R&D and CMC with nonclinical evaluation and early clinical translation. The platform delivers full-spectrum technical support spanning lead optimization, developability assessment, and early-stage customized CMC strategy for global biotech partners.Rui
More news about: AsymBio
Jul 26, 2026, 22:29 ET 【祝賀】亞盛醫藥楊大俊榮登《The Medicine Maker》2026全球最具影響力人物榜
《The Medicine Maker》是全球製藥產業鏈極具影響力的專業媒體，聚焦藥物研發、CMC 工藝開發、產業化落地與新藥商業化。一年一度的The Power List榜單自推出以來，持續收錄企業領袖、頂尖科學家等全球醫藥領域傑出人物，代表了推動全球醫藥創新的關鍵力量。該榜單已成為評估行業影響力的重要參考。
More news about: 亞盛醫藥
Jul 23, 2026, 06:45 ET Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
presented at future medical meetings and published in peer-reviewed journals. Lilly is completing the comprehensive Chemistry, Manufacturing, and Controls (CMC) data package required for a Biologics License Application (BLA) and plans to subsequently submit retatrutide in Q1 2027 for U.S. approval.About
More news about: Eli Lilly and Company
Jul 21, 2026, 09:06 ET DES Pharma Consulting and Adept Packaging Form Strategic Alliance to Accelerate Drug Development and Commercialization
Strategic alliance integrates CMC, quality, and packaging expertise to help biotech and pharmaceutical companies reduce development risk, improve regulatory readiness, and accelerate commercialization.NEW YORK,
More news about: Adept Group LLC
Jul 21, 2026, 08:13 ET Wheeler Bio Appoints Rajesh Beri, Ph.D., as Chief Development Officer
supporting integrated CMC programs from cell line development through Drug Substance and Drug Product manufacturing. He will oversee the scientific strategy supporting Wheeler Bio's signature ModularCMC® platform, with an eye on continuous improvement while delivering to our partners a CMC strategy that reduces
More news about: Wheeler Bio, Inc.
Jul 20, 2026, 07:00 ET Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02
FDA submissions address all feedback on clinical, CMC, and regulatory topics from the End-of-Phase 2 meetingFour AP-SA02 engineering runs completed; clinical trial material production is the next planned manufacturing stepPhase
More news about: Armata Pharmaceuticals, Inc.
Jul 17, 2026, 10:54 ET L7 Informatics Names Ray Veeraraghavan, Ph.D., Vice President of Science and AI
execution substrate that can be layered on top of your existing systems. Whether you are managing a large portfolio of small and large molecules through CMC development phases or processing thousands of samples for molecular diagnostics, or scaling cell therapies from research to commercialization, L7 unifies
More news about: L7 Informatics
Jul 14, 2026, 20:00 ET Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
manufacturing partner into a broader drug innovation ecosystem. By combining Insilico's AI-native capabilities with Bora's global expertise in formulation, CMC, regulatory development, scale-up, quality, commercial manufacturing, supply chain, and commercialization, we have an opportunity to create a truly integrated
More news about: Insilico Medicine
Jul 14, 2026, 12:00 ET ACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process
research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.Through
More news about: ACROBiosystems Group
Jul 13, 2026, 12:00 ET Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities
research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.Through
More news about: ACROBiosystems
Jul 13, 2026, 04:56 ET Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline
portfolios.Leads Biolabs has established integrated capabilities across early discovery, translational medicine, clinical development, CMC and business development. The innovative nature and competitive strengths of its drug candidates, coupled with its global perspectives, proactive strategy,
More news about: Leads Biolabs
Jul 10, 2026, 04:53 ET Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC
antibody portfolios.Leads Biolabs has established integrated capabilities across early discovery, translational medicine, clinical development, CMC and business development. The innovative nature and competitive strengths of its drug candidates, coupled with its global perspectives, proactive strategy,
More news about: Nanjing Leads Biolabs Co., Ltd.
Jul 09, 2026, 10:00 ET SAI-DA 1.0 | GEOTA Platform: Revolutionizing Drug R&D with Digital Computing Power
limitations of the traditional sequential development model by enabling the parallel acceleration of clinical translation and CMC process development for commercialization.On the CMC side, AI-Advance™ intelligently predicts critical parameters for formulation development, process scale-up, and other key
More news about: Sanyou Bio
Jul 08, 2026, 12:00 ET On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations
innovation fountain, not a cost-driven market. To succeed, Chinese biotechs must provide globally transferable GCP/GLP-compliant data, English-language CMC documentation, globally-oriented trial designs, and focused, prioritized pipelines.A second panel explored M&A versus licensing strategies.
More news about: bioSeedin
Jul 08, 2026, 09:00 ET Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
has developed specialized CRO and CDMO platforms focusing on plasmids, viral vectors (lentiviral vector, adenoviral vector, AAV, etc.), cell therapy CMC services including CAR-T, TCR-T, CAR-NK, HSC, exosome, etc., bacterial vector and nucleic acid therapies. Our state-of-the-art, GMP-compliant facilities
More news about: Porton Advanced
Jul 06, 2026, 15:20 ET MedStar Health Offers New Thumb Joint Replacement for Thumb Arthritis
Baltimore became the first in their respective regions to perform a break-through treatment for patients living with debilitating thumb carpometacarpal (CMC) arthritis. The painful condition, also known as basal joint arthritis or rhizarthrosis, is one of the most common forms of hand arthritis in the U.S.,
More news about: MedStar Health
Jul 01, 2026, 08:52 ET ProBio's AAV Manufacturing Excellence Powers UC Irvine and GlyTR Therapeutics First‑in‑Class pan-cancer CAR‑T Program
IND-enabling studies. The program leverages ProBio's integrated CDMO capabilities including plasmid DNA development, GMP manufacturing, and scalable CMC expertise to de‑risk early development and accelerate the path toward clinical evaluation.Dr. Ani Grigorian, Associate Project Scientist at the
More news about: ProBio Inc.
Jun 30, 2026, 10:17 ET Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics
design, modification optimization, process development, and CMC studies.Industry Leaders Discuss the Road AheadThe event concluded with a roundtable discussion that brought together perspectives from across scientific innovation, CMC development, regulatory review, capital markets, and
More news about: Tsingke Biotech
Jun 30, 2026, 10:17 ET Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics
design, modification optimization, process development, and CMC studies.Industry Leaders Discuss the Road AheadThe event concluded with a roundtable discussion that brought together perspectives from across scientific innovation, CMC development, regulatory review, capital markets, and
More news about: Tsingke Biotech
Jun 30, 2026, 08:45 ET Molex Delivers Next-Generation HSAutoLink G Automotive Ethernet Connector System to Address Rising ADAS/Compute Demands and Zonal Architectures
CMC/CMX connector system and
More news about: Molex Incorporated
Jun 29, 2026, 12:00 ET Frontage Laboratories Is Pleased to Welcome Dr. Chandra Prakash, Ph.D., as Senior Advisor, Clinical Services
seamless end-to-end capabilities – from drug discovery, API synthesis, DMPK, and safety & toxicology to formulation development and manufacturing, CMC analytical, clinical trials, bioanalytical and central lab services. With deep scientific expertise and strong operational execution, Frontage supports
More news about: Frontage Laboratories, Inc.